Evidence map›Paper›PMID 27431285›Full record

ArticleBMC medical ethics2016

Conceptual and terminological confusion around personalised medicine: a coping strategy.

Giovanni De Grandis, Vidar Halgunset

Abstract read
In one paragraph

Article in BMC medical ethics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Exploring interdisciplinary perspectives on the implementation ofJournal of Alzheimer's disease : JAD · 2025
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. The prospects of precision psychiatry.Theoretical medicine and bioethics · 2021
    Article
  9. Review
  10. The personalized medicine discourse: archaeology and genealogy.Medicine, health care, and philosophy · 2021
    Article
  11. Review
  12. Knowledge repositories. In digital knowledge we trust.Medicine, health care, and philosophy · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. I'veInternational journal of molecular sciences · 2018
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Giovanni De GrandisDepartment of Philosophy and Religious Studies, Norwegian University of Science and Technology, NTNU Dragvoll, 7491, Trondheim, Norway. giovanni.de.grandis@ntnu.no.ORCID 0000-0002-1948-7467
Vidar HalgunsetDepartment of Philosophy and Religious Studies, Norwegian University of Science and Technology, NTNU Dragvoll, 7491, Trondheim, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe idea of personalised medicine (PM) has gathered momentum recently, attracting funding and generating hopes as well as scepticism. As PM gives rise to differing interpretations, there have been several attempts to clarify the concept. In an influential paper published in this journal, Schleidgen and colleagues have proposed a precise and narrow definition of PM on the basis of a systematic literature review. Given that their conclusion is at odds with those of other recent attempts to understand PM, we consider whether their systematic review gives them an edge over competing interpretations. DISCUSSION: We have found some methodological weaknesses and questionable assumptions in Schleidgen and colleagues' attempt to provide a more specific definition of PM. Our perplexities concern the lack of criteria for assessing the epistemic strength of the definitions that they consider, as well as the logical principles used to extract a more precise definition, the narrowness of the pool from which they have drawn their empirical data, and finally their overlooking the fact that definitions depend on the context of use. We are also worried that their ethical assumption that only patients' interests are legitimate is too simplistic and drives all other stakeholders' interests-including those that are justifiable-underground, thus compromising any hope of a transparent and fair negotiation among a plurality of actors and interests.

conclusionAs an alternative to the shortcomings of attempting a semantic disciplining of the concept we propose a pragmatic approach. Rather than considering PM to be a scientific concept in need of precise demarcation, we look at it as an open and negotiable concept used in a variety of contexts including at the level of orienting research goals and policy objectives. We believe that since PM is still more an ideal than an achieved reality, a plurality of visions is to be expected and we need to pay attention to the people, reasons and interests behind these alternative conceptions. In other words, the logic and politics of PM cannot be disentangled and disagreements need to be tackled addressing the normative and strategic conflicts behind them.

Indexed as

Ethics, ResearchPrecision MedicineResearchSemanticsTerminology as TopicComprehensionConfusionHumansConceptual confusionContextual meaningDefinitionHealthcare policyMedical ethicsMethodologyPersonalised medicineResearch policySystematic literature reviewThe politics of naming

Identifiers

PMID27431285
PMCPMC4950113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.